The neurobiology of social phobia

European Archives of Psychiatry and Clinical Neuroscience

Volumn 249, Issue SUPPL., 1999, Pages

  Bell, C J ^a   Malizia, A L ^a   Nutt, D J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Imaging; Neurobiology; PET; Social phobia

Indexed keywords

4 AMINOBUTYRIC ACID; ADRENALIN; CAFFEINE; CARBON DIOXIDE; CHOLECYSTOKININ; FLUMAZENIL; GROWTH HORMONE; LACTIC ACID; MONOAMINE OXIDASE INHIBITOR; NEUROTRANSMITTER; SEROTONIN UPTAKE INHIBITOR;

ADRENAL FUNCTION; ADRENERGIC SYSTEM; ANXIETY NEUROSIS; BRAIN ELECTROPHYSIOLOGY; DOPAMINERGIC SYSTEM; HUMAN; ISOTOPE LABELING; MAJOR CLINICAL STUDY; NEUROBIOLOGY; ONSET AGE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; SOCIAL PHOBIA; THYROID FUNCTION;

BRAIN; CAFFEINE; CARBON DIOXIDE; CHOLECYSTOKININ; EPINEPHRINE; FEMALE; FLUMAZENIL; HUMAN GROWTH HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LACTIC ACID; MALE; NEUROTRANSMITTER AGENTS; PANIC DISORDER; PHOBIC DISORDERS; PITUITARY-ADRENAL SYSTEM; THYROID GLAND; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033009973     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00014162     Document Type: Review

References (53)

1. Baxter LR, Schwartz JM, Bergman KS et al. (1992) Caudate metabolic rate changes with both drug and behaviour therapy for OCD. Arch Gen Psychiatry 49: 681-689
2. Bradwejn J (1997) CCK oral presentation BAP summer meeting Cambridge, July 1997
3. Bruce M, Scott N, Shine P et al. (1991) Anxiogenic effects of caffeine in patients with anxiety disorders. Archives of Gen Psych 49: 867-869
4. Coupland NJ, Bailey JE, Potakar JP et al. (1995) Abnormal cardiovascular responses to standing in panic disorder and social phobia. BAP summer meeting, Cambridge. J Psychopharmacology 9 (3) suppl A19: 73
5. Cowley D, Arana G (1990) The diagnostic utility of lactate sensitivity in panic disorder. Arch Gen Psychiatry 47: 277-284
6. Davidson JR, Krishnan KR, Charles HC et al. (1993) Magnetic resonance spectroscopy in social phobia: preliminary findings. J Clin Psychiatry 54 Suppl: 19-25
7. Ebert D, Feistel H, Loew T et al. (1996) Dopamine and depression-striatal dopamine D2 receptor SPECT before and after antidepressant therapy. Psychopharmacol 126: 91-4
8. Emmanuel NP, Lydiard RB, Ballenger JC (1991) Treatment of social phobia with bupropion (letter). J Clin Psychopharmacol 11: 276-277
9. Goldstein S (1987) Treatment of social phobia with clonidine. Biol Psychiatry 22: 369-372
10. German J, Fyer M, Goetz et al. (1988) Ventilatory physiology of patients with panic disorder. Arch Gen Psychiatry 45: 31-39
11. German J, Papp LA, Martinez J et al. (1990) High dose CO2 challenge test in anxiety disorder patients. Biol Psychiatry 28: 743-757
12. Graeff FG, Guimeras TS, De Andrade TG (1996) Role of 5-HT in stress, anxiety and depression. Pharmacology, Biochemistry and Behaviour 54: 129-141
13. Heimberg RG, Hope DA, Dodge CS et al. (1990) DSM-IIIR subtypes of social phobia; comparison of generalised phobics and public speaking phobics. J Nerv Ment Dis 178: 172-179
14. Hollander E, Decaria CM, Trungold S et al. (1989) 5-HT function and neurology of social phobia. Presented at the Annual Meeting of the American Psychiatric Association, New Orleans
15. Holt PE, Andrews G (1989) Provocation of panic; three elements of the panic reaction in four anxiety disorders. Behav Res Ther 27: 253-261
16. Johnson M, Lydiard R, Zealberg J et al. (1994) Plasma and CSF HVA levels in panic patients with comorbid social phobia. Biol Psychiatry 36: 425-427
17. Kalueff AV, Nutt DJ (1997) The role of GABA in memory and anxiety. Anxiety 4 (3): 100-110
18. King R, Mefford I, Wang C et al. (1986) CSF dopamine levels correlate with extraversion in depressed patients. Psychiatr Res 19: 305
19. Levin AP, Saoud J, Strauman T et al. (1993) Responses of generalised and discrete social phobies during public speaking. J Affective Disorders 7: 207-221
20. Liebowitz MR, Campeas R, Hollander E (1987) MAOIs; Impact on social phobia on social behaviour (letter). Psychiatry Res 22: 89-90
21. Liebowitz MR, Fyer AJ, Gorman JM et al. (1985) Specificity of lactate infusions in social phobia versus panic disorders. Am J Psychiatry 142: 947-950
22. Liebowitz MR, Fyer AJ, Gorman JM et al. (1986) Phenelzine in social phobia. J Clin Psychopharmacol 6: 93-98
23. Liebowitz MR, Schneier F, Campeas R et al. (1992) Phenelzine vs atenolol in social phobia. Arch Gen Psychiatry 49: 290-300
24. Magee WJ, Eaton WW, Wittchen HU et al. (1996) Agoraphobia, simple phobia and social phobia in the National Comorbity Survey. Arch Gen Psychiatry 53: 159-168
25. Malizia AL (1997) PET studies in experimental and pathological anxiety. J Psychopharmacol 11 (3): A88
26. Malizia AL, Wilson SJ, Bell CM, Nutt DJ, Grasby PM (1997) Neural correlates of anxiety provocation in Social Phobia. Neuroimage 5, 4, part 2: S301
27. A-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Archives Gen Psychiatry 55: 715-720
28. Mayleben M, Gariepy J, Tancer M et al. (1992) Genetic differences in social behaviour; neurobiological mechanisms in a mouse model. Biol Psychiatry 31 (suppl): 216A
29. Mikkelson EJ, Deltor J, Cohen DJ (1981) School avoidance and social phobia triggered by haloperiods in patients with Tourette's Syndrome. Am J Psychiatry 138: 1572-1576
30. Merikangas KR, Angst J (1995) Comorbidity and social phobia: evidence from clinical, epidemiologic and genetic studies. Eur Arch Psychiatry Clin Neurosci 244: 297-303
31. Papp LA, Gorman JM, Liebowitz MR et al. (1988) Epinephrine infusions in patients with social phobia. Am J Psychiatry 145: 733-736
32. Potts NLS, Davidson JRT, Krishnan KR et al. (1992) Levels of urinary free cortisol in social phobia. J Clin Psychiatry 52 (11, suppl): 41-42
33. Potts NLS, Davidson JRT, Krishnan KR et al. (1994) Magnetic resonance imaging in social phobia. Psychiatry Res 52: 35-42
34. Price CJ, Friston KJ (1997) Cognitive conjunction: a new approach to brain activation experiments. Neuroimage 5: 261-270
35. Rauch SL, Jenike MA, Alpert NM et al. (1994) Regional cerebral blood flow measured during symptom provocation in OCD. Arch Gen Psychiatry 51: 62-70
36. Reiter SR, Pollack MH, Rosenbaum JF et al. (1990) Clonazepam for the treatment of social phobia. J Clin Psychiatry 51: 470-472
37. Sapolsky RM (1989) Hypercortisolemia among socially subordinate wild baboons at the CNS level. Arch Gen Psychiatry 46: 1047-1051
38. th, University of North Carolina, Chapel Hill, NC
39. Stein MB, Asmundson G, Chartier M (1994) Autonomic responsivity in generalised social phobia. J Affective Disorders 31: 211-221
40. Stein MB, Delaney SM, Chartiet M et al. (1995) 3H paroxetine binding to platelets of patients with social phobia; comparison to patients with panic disorder and healthy volunteers. Biol Psychiatry 37: 224-228
41. Stein MB, Leslie WD (1996) A brain SPECT study of social phobia. Biol Psychiatry 39: 825-828
42. Tancer ME (1993) Neurobiology of social phobia. J Clin Psychiatry 54: 26-30
43. Tancer ME, Golden RN (1992) Monoamine neurotransmitter function in social phobia. Presented as a Travel Award Poster at the annual meeting of the American College of Neuropsychopharmacology; December 15, San Juan, Puerto Rico
44. Tancer ME, Stein MB, Bessette BB et al. (1990) The hypothalmicpituitary-thyroid axis in social phobia. Am J Psychiatry 147: 929-933
45. Tancer ME, Stein MB, Uhde TW (1990) Effects of TRH on blood pressure and heart rate in social phobia patients, panic disorder patients and normal controls; results of a pilot study. Biol Psychiatry 27: 781-783
46. Tancer ME, Stein MB, Uhde TW (1994) Growth hormone response to IV clonidine in social phobia; comparison to patients with panic disorder and healthy volunteers. Biol Psychiatry 34: 252-256
47. Tancer ME, Stein MB, Uhde TW (1991) Lactate response to caffeine in panic disorder; a replication using an 'anxious control group'. Biol Psychiatry 29: 57
48. Tiihonen J, Kuikka J, Bergstrom K, Lepola U, Koponen H, Leinonen E (1997) Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 154: 239-242
49. Uhde T (1994) Anxiety and growth disturbance; is there a connection? A review of biological studies in social phobia. J Clin Psychiatry 55: 6 (supply): 17-27
50. Uhde T, Tancer ME, Gelernter CS et al. (1994) Normal urinary free cortisol and postdexamethasone cortisol in social phobia; comparison to normal volunteers. J Affect Disord 30: 155-161
51. Uhde T, Terrill DR, Chambless DL et al. (1993) Pentagastrin model of anxiety in humans. Presented at the annual meeting of the American College of Neuropsychopharmacology; Dec Honolulu, Hawaii
52. Van Dyck R (1996) Non-drug treatment for social phobia. Int Clin Psychopharmacol 11 (suppl 3): 65-70
53. Versiani M, Nardi AE, Mundim FD et al. (1992) Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 161: 353-360